Metabolix, Inc. is implementing a strategic plan under which the Company has wound down its legacy PHA biopolymer business and Yield10 Bioscience will become its core business with a focus on developing disruptive technologies for step-change improvements in crop yield. Yield10 is leveraging Metabolix’s extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing several yield traits in development in crops such as camelina, canola, soybean and corn. The Company is based in Woburn, Mass.
Whether you are a long-time shareholder in Metabolix or just beginning to consider an investment in our company, we are committed to providing you with useful information and convenient tools you need to make informed decisions about your investment.
Investors should note that we announce material information to our investors using our website, SEC filings, press releases, public conference calls and webcasts. We use these channels, as well as social media, to communicate with our shareholders and the public about our company, our products and other matters. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in our company to review the information we post on the social media channels listed at the top of our website.
View all » Recent Releases
View all »Events & Presentations
Dec 3, 2015
Yield10: Canola Innovation Day 2015
View Presentation 1.6 MB
View all »Recent SEC Filings
|DEF 14A||definitive proxy statement||Nov 22, 2016|
|10-Q||quarterly report||Nov 18, 2016|
|NT 10-Q||notification of late filing||Nov 15, 2016|
|8-K||current report||Nov 9, 2016|
|8-K||current report||Nov 8, 2016|
|4||shaulson, joseph h||Nov 8, 2016|